Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SKAP2 acts downstream of CD11b/CD18 and regulates neutrophil effector function.
Bouti P, Klein BJAM, Verkuijlen PJH, Schornagel K, van Alphen FPJ, Taris KH, van den Biggelaar M, Hoogendijk AJ, van Bruggen R, Kuijpers TW, Matlung HL. Bouti P, et al. Among authors: van bruggen r. Front Immunol. 2024 Feb 29;15:1344761. doi: 10.3389/fimmu.2024.1344761. eCollection 2024. Front Immunol. 2024. PMID: 38487529 Free PMC article.
Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRPα Checkpoint Disruption.
Bouti P, Zhao XW, Verkuijlen PJJH, Tool ATJ, van Houdt M, Köker N, Köker MY, Keskin O, Akbayram S, van Bruggen R, Kuijpers TW, Matlung HL, van den Berg TK. Bouti P, et al. Among authors: van houdt m, van den berg tk, van bruggen r. Cancer Immunol Res. 2021 Feb;9(2):147-155. doi: 10.1158/2326-6066.CIR-20-0491. Epub 2020 Dec 22. Cancer Immunol Res. 2021. PMID: 33355195
Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes.
Martinez-Sanz P, Laurent ARG, Slot E, Hoogenboezem M, Bąbała N, van Bruggen R, Rongvaux A, Flavell RA, Tytgat GAM, Franke K, Matlung HL, Kuijpers TW, Amsen D, Karrich JJ. Martinez-Sanz P, et al. Among authors: van bruggen r. Front Immunol. 2023 Mar 8;14:1105103. doi: 10.3389/fimmu.2023.1105103. eCollection 2023. Front Immunol. 2023. PMID: 36969261 Free PMC article.
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
Treffers LW, van Houdt M, Bruggeman CW, Heineke MH, Zhao XW, van der Heijden J, Nagelkerke SQ, Verkuijlen PJJH, Geissler J, Lissenberg-Thunnissen S, Valerius T, Peipp M, Franke K, van Bruggen R, Kuijpers TW, van Egmond M, Vidarsson G, Matlung HL, van den Berg TK. Treffers LW, et al. Among authors: van houdt m, van den berg tk, van bruggen r, van egmond m, van der heijden j. Front Immunol. 2019 Jan 30;9:3124. doi: 10.3389/fimmu.2018.03124. eCollection 2018. Front Immunol. 2019. PMID: 30761158 Free PMC article.
Neutrophils as Suppressors of T Cell Proliferation: Does Age Matter?
Aarts CEM, Hiemstra IH, Tool ATJ, van den Berg TK, Mul E, van Bruggen R, Kuijpers TW. Aarts CEM, et al. Among authors: van den berg tk, van bruggen r. Front Immunol. 2019 Sep 11;10:2144. doi: 10.3389/fimmu.2019.02144. eCollection 2019. Front Immunol. 2019. PMID: 31572368 Free PMC article.
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P, van Rees DJ, van Zogchel LMJ, Klein B, Bouti P, Olsman H, Schornagel K, Kok I, Sunak A, Leeuwenburg K, Timmerman I, Dierselhuis MP, Kholosy WM, Molenaar JJ, van Bruggen R, van den Berg TK, Kuijpers TW, Matlung HL, Tytgat GAM, Franke K. Martinez Sanz P, et al. Among authors: van den berg tk, van bruggen r, van rees dj, van zogchel lmj. J Immunother Cancer. 2021 May;9(5):e002259. doi: 10.1136/jitc-2020-002259. J Immunother Cancer. 2021. PMID: 34049929 Free PMC article.
Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing.
van Rees DJ, Brinkhaus M, Klein B, Verkuijlen P, Tool ATJ, Schornagel K, Treffers LW, van Houdt M, Kater AP, Vidarsson G, Gennery AR, Kuijpers TW, van Bruggen R, Matlung HL, van den Berg TK. van Rees DJ, et al. Among authors: van houdt m, van den berg tk, van bruggen r. Blood Adv. 2022 Apr 12;6(7):2156-2166. doi: 10.1182/bloodadvances.2021005367. Blood Adv. 2022. PMID: 34942000 Free PMC article.
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
van Rees DJ, Bouti P, Klein B, Verkuijlen PJH, van Houdt M, Schornagel K, Tool ATJ, Venet D, Sotiriou C, El-Abed S, Izquierdo M, Guillaume S, Saura C, Di Cosimo S, Huober J, Roylance R, Kim SB, Kuijpers TW, van Bruggen R, van den Berg TK, Matlung HL. van Rees DJ, et al. Among authors: van houdt m, van den berg tk, van bruggen r. J Immunother Cancer. 2022 Jun;10(6):e004820. doi: 10.1136/jitc-2022-004820. J Immunother Cancer. 2022. PMID: 35728876 Free PMC article.
162 results